The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
The launch coincides with IBS Awareness Month in April
PMDA is regarded among the most stringent regulatory bodies globally
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
The innovation is particularly suited for bone and cartilage repair
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Subscribe To Our Newsletter & Stay Updated
